PLAY PODCASTS
A Personal Struggle Fuels National Advocacy for Rare Disease Patients: Shanti Hegde, Board Member of Hemophilia Federation of America
Episode 568

A Personal Struggle Fuels National Advocacy for Rare Disease Patients: Shanti Hegde, Board Member of Hemophilia Federation of America

We’re marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate whose efforts to transform how bleeding disorders are understood, treated, and supported is fueled by her personal struggle with these conditions. Join host Lindsey Smith for a remarkable Year of the Zebra conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require.

Raise the Line · Shanti Hegde, Lindsey Smith

February 26, 202645m 19s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

We’re marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate working to transform how bleeding disorders are understood, treated, and supported. This work is fueled by her own arduous journey with two rare bleeding disorders and immune dysregulatory syndrome, and an extended diagnostic odyssey marked by dismissal, underdiagnosis, and structural bias. “I was told many times by many providers that these disorders are not common in Indians and that my bruises were there just because I'm brown.” Admirably, Shanthi pushed past this mistreatment, advocated for her medical needs, and devoted herself to tackling a range of issues confronting rare disease patients from mental health access to affordable drug pricing to research equity.

In this remarkable Year of the Zebra conversation with host Lindsey Smith, you’ll also learn about:

  • Shanti’s work with the Hemophilia Federation of America;
  • How gaps extend beyond treatment to include insurance coverage, provider training, and substance use care;
  • What clinicians can do to improve the work they do with rare disease patients.

Join us for a conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require.

Mentioned in this episode:
Hemophilia Federation of America
Shanthi's LinkedIn Profile

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Topics

maria pfrommerhealthcare technologydrug costshemophiliadrug developmentcontinuing educationjohns hopkins universitydoctorsmedical degreescoronavirushome caredigital healthhealth insurancewearablesrare bleeding disordersfrontline providersosmosis from elsevierpfizerfdapatient advocacygovernment policypsilocybinmedicareraise the linevirusmachine learningspaced repetitioneducation innovationpharmaceuticalshospital staysinterviewnursing schoolflatten the curvemichael carreseelsevieraishanti hegdehealthcare entrepreneursnursesprimary carehealthcare capacityhealthcare reformbig pharmaastra zenecacovid-19kelsey lafayetterare disordershealthcare workforceexpertsmedical educationnursingnursing shortageimmune dysregulatory syndromein-home carelsdmedicaidlearning sciencegene editingvalue-based careflipped classroommedicare advantagenursing educationphysician shortagecmeprovider burnoutcdcepidemicosmosisbleeding disordersremote monitoringhealthcare systemmark cubanosmosis.orgdecision supportrare diseasesvirus outbreakjannah amielonline educationallied health professionspublic policyhillary acercovid19caleb furnasedtechshiv gaglanimdmahemophilia federation of americamodernaphysician assistant educationvivian leechelsea clintonpodcastsliz lucasnursing degreederek apanovitchpsychedelicslindsey smithhospital systemspublic healthdr. ashish jhavaccineseric topolyear of the zebradental educationtestingcenters for disease controlpsychedelic-assisted therapyhealth professionspandemicjohnson & johnsontelehealth